Automated Assessment of Difficult Airway With Facial Recognition Techniques
Launched by UNIVERSITY OF LAUSANNE HOSPITALS · Dec 20, 2013
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the safety of patients undergoing general anesthesia, which often requires a procedure called tracheal intubation to help them breathe. Researchers are developing new technologies that use images and videos to automatically identify features in a person's anatomy that could make intubation more difficult. By accurately recognizing these features before surgery, the medical team can better prepare and adjust their approach, ultimately helping to prevent complications and improve patient safety.
To participate in this trial, you need to be an adult (15 years or older) who requires intubation for general anesthesia. If you agree to join, you may be involved in testing this new technology. It's important to know that if you do not want to participate, you can simply refuse, and that is completely okay. The study is currently looking for volunteers, and both men and women are welcome to apply. This research aims to enhance the care provided to patients like you during surgeries involving anesthesia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patient (15 years of age)
- • patients necessitating endotracheal intubation for general anesthesia
- Exclusion Criteria:
- • -patient refusal
About University Of Lausanne Hospitals
The University of Lausanne Hospitals (CHUV) is a leading academic medical center in Switzerland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, CHUV focuses on translating scientific discoveries into effective treatments, fostering collaboration between researchers, healthcare professionals, and industry partners. With state-of-the-art facilities and a multidisciplinary approach, CHUV is dedicated to enhancing patient outcomes and contributing to the global body of medical knowledge through rigorous clinical trials across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lausanne, Vd, Switzerland
Patients applied
Trial Officials
Patrick Schoettker, Assoc Prof
Principal Investigator
University of Lausanne Hospitals
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials